SCHEMBL20039984

SCHEMBL20039984

Cc1ccc([C@@H]2CCC[C@H](CNc3ncnc(C(=O)N4CCC(C)CC4)c3C)O2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.46
CCR5 P51681 2/20 0.46
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
BTK Q06187 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
TRPC3 Q13507 1/20 0.35
TRPC6 Q9Y210 1/20 0.35
PAK1 Q13153 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KMT2A Q03164 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
TNK2 Q07912 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18924971 0.92 CCR2 (0.47) CCR2CCR5BTKHPGDPAK1
SCHEMBL24176496 0.92 CCR2 (0.47) CCR2CCR5BTKHPGDPAK1
SCHEMBL3110116 0.90 CCR2 (0.44) CCR2CCR5BTKHPGDPAK1
SCHEMBL15966231 0.90 CCR2 (0.44) CCR2CCR5BTKHPGDPAK1
SCHEMBL18215076 0.87 CCR2 (0.46) CCR2CCR5BTKALDH1A1PAK1
SCHEMBL15033716 0.87 CCR2 (0.46) CCR2CCR5BTKALDH1A1HPGD
SCHEMBL24176138 0.85 CCR2 (0.46) CCR2CCR5BTKALDH1A1HPGD
SCHEMBL24176498 0.85 CCR2 (0.46) CCR2CCR5BTKALDH1A1HPGD
SCHEMBL3053389 0.85 CCR2 (0.41) CCR2CCR5HPGDKDM4ESMN1; SMN2
SCHEMBL3052720 0.85 CCR2 (0.41) CCR2CCR5HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091012-B1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF CENTREXION THERAPEUTICS CORP (US) 2018-04-11 EP disclosed